NeuroRehab Team
Thursday, December 4th, 2025
Neurological conditions bring spasticity to many patients. The numbers are striking – 80% of spinal cord injury patients, 39.5% of stroke patients with paresis, and 84% of those with multiple sclerosis experience this condition. Traditional treatments like oral anti-spasmodics and botulinum toxin injections help patients find relief, yet they have their limitations. Botulinum toxin stands as a first-line treatment for focal spasticity, but its effects last only 3-4 months before requiring another treatment.